Chugai Pharma Europe Combines SSO, MFA and VPN-less Remote Access with CyberArk Identity

September 21, 2020

Chugai replaced three costly products with a single, cost-effective solution to fully address SSO, MFA and EMM requirements.

“Today, with CyberArk Identity, we’ve got one centralized identity management solution that covers our single-sign-on needs across all apps and addresses our EMM and MFA requirements as well. That has saved us money and IT resources, and allows us to build very specific policies around application access.” David Howell, IT Associate Director at Chugai Pharma Europe Ltd.

Chugai Pharmaceutical Co Ltd. is Japan’s leading biopharmaceutical company. A member of the Roche Group, Chugai’s mission is to add exceptional value through the creation of innovative medical products and services for the benefit of the medical community and human health around the world. Chugai Pharma Europe Ltd (CPE), is a subsidiary of Chugai Pharmaceutical Co Ltd, responsible for the European input to Chugai’s global product development pipeline. CPE is an integral part of developing product candidates through to Market.

Previous Flipbook
London Hydro securely enables its move to the cloud with CyberArk Identity
London Hydro securely enables its move to the cloud with CyberArk Identity

CyberArk Identity securely enables London Hydro’s move to the Cloud.

Next Flipbook
Rémy Cointreau secures an agile approach to a more cloud-based infrastructure with CyberArk Identity
Rémy Cointreau secures an agile approach to a more cloud-based infrastructure with CyberArk Identity

Rémy Cointreau improves productivity by deploying CyberArk Identity

Gartner Names CyberArk a Leader in the 2021 Magic Quadrant for PAM

Download Now